ZimVie’s $1B sales forecast, Aurora Spine’s patent nod and more: 4 device company notes

How Zimmer Biomet performed in the fourth quarter of 2021 and three more updates from spine and orthopedic device companies:

Advertisement

1. Orthobiologics technology company Bone Solutions received FDA 510(k) clearance for its Mg Osteorevive bone void filler.

2. Zimmer Biomet saw a 2.3 percent dip in its fourth-quarter sales year over year and set a completion date of March 1 for its spine and dental spinoff, ZimVie. Read more details here.

3. Aurora Spine received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent related to the ZipFlex device.

4. Zimmer Biomet’s spine and dental spinoff, ZimVie, is expected to earn $1 billion in revenue, with an adjusted EBITDA margin of 13.1 to 13.6 percent.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.